-+ 0.00%
-+ 0.00%
-+ 0.00%

INMUNE BIO ADVANCES EBSTROCEL™ TOWARD POTENTIAL UK APPROVAL IN MID-2027

Reuters·10/21/2026 11:15:09

Please log in to view news